MannKind (MNKD) & Sanofi (SNY) Are Likely To Climb More Soon!

MannKind Corporation (NASDAQ: MNKD) | Sanofi SA (ADR) (NYSE: SNY) If you follow my writing here or elsewhere, you know that MannKind stock is one of my favorite topics. The company developed an inhaled insulin called Afrezza that I have high hopes for; and that’s where Sanofi comes in. When it comes to Afrezza, it’s … Read more

MannKind (MNKD) Stock Reaches Support | Time For Gains

MannKind Corporation (NASDAQ: MNKD) After a bullish run that lasted about 3 weeks, MannKind has had a tough week in the market this week. However, as I’ve mentioned since the stock started downtrends, I wasn’t too concerned. As a matter of fact, I saw the declines as an opportunity; and it looks like today is … Read more

MannKind (MNKD) Stock Continues Falling | When Will We See Gains

MannKind Corporation (NASDAQ: MNKD) MannKind Corporation has been an incredibly interesting stock to watch recently. After struggling a few months back thanks to a Goldman Sachs downgrade; a research note from Jefferies sent the stock back in bullish mode over the past couple of weeks. However, this week has been a bit of a different … Read more

MannKind (MNKD) Stock Is Exploding | You’re Not Too Late For Gains!

MannKind Corporation (NASDAQ: MNKD) If you follow CNA Finance or my writing elsewhere, you probably already know that MannKind is and has been one of my favorite biotech stocks for quite some time. While I may have gotten a bit of backlash for my opinion on MNKD in the past; it’s clear that recently, investors … Read more

MannKind (MNKD) Climbs Again | How Long Can It Continue?

MannKind Corporation (NASDAQ: MNKD) MannKind stock has been back on the rise recently after the months of declines we saw following the unfounded Goldman Sachs downgrade. Earlier in the month, Jefferies publsihed the results of a survey that showed that physicians haven’t just heard about Afrezza, but they’re likely to start using it more in … Read more

MannKind (MNKD) Stock Is Back On The Rise | What Will Happen Next!

MannKind Corporation (NASDAQ: MNKD) MannKind Corporation has had a bit of a hard time over the past few months. However, about 2 weeks ago, that all changed as a Jefferies research note showed that 65% of the endocrinologists they surveyed stated that they not only knew about Afrezza, but plan to start using it more … Read more